Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)(520500.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)
520500.SH
News
View More

Top 5 HK Stock Gainers/Losers (>100B) (1.21)

GIGADEVICE(03986) rose 6.14%, with a trading turnover 758.6 Million HKD, and a year-to-date rose 100.5%. GANFENGLITHIUM(01772) rose 5.54%, with a trading turnover 926.9 Million HKD, and a year-to-date rose 26.5%. ANTA SPORTS(02020) fell 4.18%, with a trading turnover 2.8 Billion HKD, and a year-to-date fell 1.8%. NTES-S(09999) fell 3.7%, with a trading turnover 2.0 Billion HKD, and a year-to-date fell 3.1%.

Top Gainers & Losers·
HK
03986
+6.14%
HK
01772
+5.54%
HK
01787
+5.49%
Top Gainers & Losers·
HK
03986
+6.14%
HK
01772
+5.54%
HK
01787
+5.49%

Ant Group upgrades AI health service AQ's PC platform with DeepSearch for evidence-based clinical decision support, available free to clinicians.

Ant Group has enhanced its AI health assistant, AQ, on its PC platform by introducing DeepSearch, a feature designed to support evidence-based clinical decision-making. This upgrade is available for free to clinicians and medical students, offering functionalities such as Health Q&A and medical literature searches. This initiative reflects Ant Group's dedication to aiding healthcare professionals in their decision-making processes.

Unusual Whales·
Unusual Whales·

Hong Kong Equities Edge Up After Recent Declines

Hong Kong stocks rose 32 points (0.1%) to 26,518, breaking a four-session losing streak, influenced by stronger U.S. futures. The rebound was led by tech and consumer sectors, reflecting gains in mainland markets after the People's Bank of China maintained lending rates. However, investor caution persisted ahead of upcoming inflation data and business confidence readings. Notable early movers included Wuxi Biologics (2.6%), SMIC (2.5%), Zijin Mining (2.2%), and China Hongqiao Group (1.9%).

Trading Economics·
US
WXXWY
+2.51%
HK
02269
+3.50%
Trading Economics·
US
WXXWY
+2.51%
HK
02269
+3.50%

Akeso sNDA for Gumokimab in Ankylosing Spondylitis Accepted for NMPA Review

Akeso Inc. announced that the National Medical Products Administration (NMPA) in China has accepted the supplemental New Drug Application (sNDA) for gumokimab (AK111), a monoclonal antibody for treating active ankylosing spondylitis. This is the second indication for gumokimab to receive NDA review, following its acceptance for psoriasis. The NDA acceptance is based on positive results from a Phase III clinical trial showing significant improvements in symptoms and quality of life for patients with the condition.

Reuters·
HK
09926
-3.06%
Reuters·
HK
09926
-3.06%

Top 5 HK Stock Gainers/Losers (>100B) (1.19)

CHINA EAST AIR(00670) rose 9.2%, with a trading turnover 216.5 Million HKD, and a year-to-date rose 6.9%. CTG DUTY-FREE(01880) rose 6.65%, with a trading turnover 350.2 Million HKD, and a year-to-date rose 10.8%. MINIMAX-WP(00100) fell 13.7%, with a trading turnover 649.0 Million HKD, and a year-to-date rose 129.1%. BILIBILI-W(09626) fell 6.85%, with a trading turnover 1.7 Billion HKD, and a year-to-date rose 25.6%.

Top Gainers & Losers·
HK
00670
-1.18%
HK
01880
+0.50%
HK
03986
+6.14%
Top Gainers & Losers·
HK
00670
-1.18%
HK
01880
+0.50%
HK
03986
+6.14%
© 2026 Longbridge｜Disclaimer